Skip to main content
Clinical Trials/RBR-3vxgjsj
RBR-3vxgjsj
Recruiting
Not Applicable

Prospective Evaluation of the Use of PET-CT with 18 F -PSMA in Hepatocarcinoma: Comparison With Conventional Morphological Methods and Impact on Management Change

Fundação Antônio Prudente - AC Camargo Cancer Center0 sitesJuly 12, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hepatocellular carcinoma
Sponsor
Fundação Antônio Prudente - AC Camargo Cancer Center
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 12, 2023
End Date
December 31, 2027
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Fundação Antônio Prudente - AC Camargo Cancer Center

Eligibility Criteria

Inclusion Criteria

  • A total of 30 patients diagnosed with established hepatocellular carcinoma will be prospectively included and analyzed with the 18F\-PSMA (Fluorine\-18 Prostate specific Membrane Antigen) PET/CT (Positron emission tomography) study

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials